A Randomized, Safety, Tolerability and Pharmacokinetics 3-Period Crossover Study Comparing 2 Single Doses of ZTI-01 and Monurol in Healthy Subjects

Trial Profile

A Randomized, Safety, Tolerability and Pharmacokinetics 3-Period Crossover Study Comparing 2 Single Doses of ZTI-01 and Monurol in Healthy Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 05 Jun 2017

At a glance

  • Drugs Fosfomycin (Primary) ; Fosfomycin tromethamine
  • Indications Pseudomonal infections
  • Focus Adverse reactions; Pharmacokinetics
  • Most Recent Events

    • 05 Jun 2017 According to the Zavante Therapeutics media release, results from the study were be presented at the ASM Microbe 2017.
    • 17 May 2017 According to the Zavante Therapeutics media release, data from the study will be presented at the ASM Microbe 2017.
    • 30 Oct 2014 Status changed from recruiting to completed according to ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top